A direct comparison for pharmaceutical companies weighing the two, focused on what actually matters for a regulated marketing team, not a general developer platform debate.
WordPress and Drupal compete less often in pharma marketing conversations than WordPress and AEM, but the decision carries the same weight for the team that has to live with it. Drupal is a genuinely capable content management system, built to model complex, highly interrelated content structures with real precision — but that flexibility comes with a specialist dependency and an upgrade cycle most pharmaceutical marketing teams never signed up for. WordPress, built as a proper component-based system rather than a single freeform text box, covers what most pharmaceutical content actually needs while handing routine changes back to the team that owns the content. This piece sets out what each platform is actually good at, where Drupal's real costs sit, and how to work out which one your organisation actually needs.
Drupal earns its reputation in scenarios most WordPress comparisons underplay: highly customised, complex content relationships and permission structures, where a development team wants fine-grained control over exactly how content types relate to each other. Taxonomies that cross-reference in genuinely complicated ways, editorial permissions tied to organisational roles, content types nested and related in patterns a simpler system would flatten — Drupal handles that well, and by design rather than as a workaround.
It is a genuinely capable platform for teams with the specialist expertise to use that flexibility properly, not a legacy choice kept alive by inertia.
The build cost is rarely what makes a Drupal decision expensive over time. The real cost shows up afterwards, in what it takes to keep the platform running and current.
Ongoing dependency on specialist Drupal developers for routine changes is the cost a typical pharmaceutical marketing team feels first and most often. Adding a page section, adjusting a content block, restructuring how a piece of content is organised — changes a marketing team would expect to handle themselves on a properly built WordPress site usually need to go through a developer with genuine Drupal experience, not a generalist. That is a consequence of the same flexibility that makes Drupal capable of the complex content modelling described above, but it means every routine update becomes a ticket, a wait, and a cost that a simpler content model would not incur.
Historically, significant rework has been required at major Drupal version upgrades rather than incremental migration, which turns a routine platform update into a project on the scale of a rebuild. See Drupal migration for how that upgrade cliff has driven many companies to reconsider the platform entirely — not because Drupal stopped working, but because the cost of staying current on it stopped being routine.
A component-based content model most marketing teams can operate independently, without the specialist development dependency Drupal often requires for equivalent day-to-day work, is the practical alternative for pharmaceutical content that does not need Drupal’s deeper taxonomy flexibility. Products, articles, team members and the other content types a pharma marketing site actually produces fit a well-designed component system cleanly, with editors adding and rearranging components themselves rather than raising a ticket for every change.
See pharmaceutical WordPress and ACF flexible content for how that editing experience is actually built, and why it holds up under real content rather than just in a demo.
Neither platform is right by default, and the honest comparison has to acknowledge what each one is actually built for.
A site with unusually complex, highly interrelated content structures that a component-based approach genuinely struggles to model is still a real case for Drupal. This is a narrower case than it once was, since most pharmaceutical content — products, articles, team members — fits a well-designed component system cleanly, but it has not disappeared. Where the content itself is the complication, not just the volume of it, Drupal’s content-modelling depth is doing something a component library was not built to do.
Drupal’s taxonomy and content-modelling flexibility remains genuinely strong for organisations with complex, deeply cross-referenced content structures and an existing in-house Drupal team. The case against it for most pharma marketing sites is the smaller specialist talent pool and steeper editorial learning curve, not a structural weakness in the platform — an important distinction, because it means the decision usually comes down to team and operating cost, not platform capability.
None of this is an argument that WordPress always wins. It is an argument for checking what your organisation’s content actually needs, and what it is currently costing you to maintain, before committing to either platform.
A Drupal major version reaching end of life is, in practice, the moment that usually forces the question, because it has historically meant a rebuild regardless of which platform comes next. See Drupal migration for how we approach that moment as an opportunity to evaluate the platform choice fresh, rather than just re-implementing the same structure on the new Drupal version by default because that is what was there before.
Before making a default decision, check the following:
If most of those answers point away from genuine content complexity and toward routine changes that keep needing a specialist, that is the practical case for moving.
The content-modelling work is the part worth taking seriously before migrating — mapping Drupal’s content types and taxonomy structure onto WordPress and ACF fields properly up front avoids flattening genuinely structured content into plain text, which is the most common quality loss in a rushed Drupal-to-WordPress move. Done properly, that mapping preserves the relationships between content types that made the original structure worth having, rather than trading Drupal’s specialist dependency for a WordPress site that has lost the organisation its content used to have.
Sometimes, and that comparison is worth running case by case rather than assumed either way — a major Drupal version upgrade can itself be substantial rework, on the scale of a rebuild, at which point migrating to a lower-dependency platform is often the better long-term investment. Checking whether your current Drupal version is approaching end of life is the first thing worth confirming before comparing costs at all.
Usually, though it is worth reassessing each component rather than replicating it exactly, since a custom module was sometimes built to work around a Drupal-specific limitation WordPress does not share. Mapping Drupal’s content types and taxonomy structure onto WordPress and ACF fields properly, rather than flattening structured content into plain text, is the part of the move worth taking seriously before anything else.
It depends mainly on content volume and how complex the custom logic and taxonomy structure are, since deeply cross-referenced content takes longer to map onto a component-based model than straightforward pages do. A Drupal major version reaching end of life is often what forces the timing of the decision, regardless of which platform comes out ahead. See how long does a pharma website take for the underlying factors.
When content structures are highly customised, with taxonomies that cross-reference in complex ways, editorial permissions tied closely to organisational roles, and content types nested and related in patterns a component-based system would flatten. That case is narrower than it once was, since most pharma content — products, articles, team members — fits a well-designed component system cleanly, but it still applies where the content itself, not only its volume, is the complication, alongside an in-house Drupal team to run it.
Tell us your current Drupal setup and we will tell you whether migrating actually makes sense.